Stock 300633 SONOSCAPE MEDICAL CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus SonoScape Medical Corp.

Equities

300633

CNE100002P91

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 30/04/2024 am IST 		5-day change 1st Jan Change
41.3 CNY -0.39% Intraday chart for SonoScape Medical Corp. +10.69% -12.68%
29/04 Nomura Adjusts Sonoscape Medical’s Price Target to 49.97 Yuan From 55.47 Yuan, Keeps at Buy MT
26/04 SonoScape Medical Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Evolution of the average Target Price on SonoScape Medical Corp.

Price target over the last 5 years

History of analyst recommendation changes

747c.o14mCeRKRSd-XP6bRv8FZF3z9tYpDn_qbZmoFht_2lY.zWlVYdUkaB5PP63tfpJRLjSnwZdvQhSmPvGcU3AuiCHHEWg91xU0RTIzvw~7d17f5ae5cf71d9285c33af76fd3de94

Analyst Recommendations on SonoScape Medical Corp.

Nomura Adjusts Sonoscape Medical’s Price Target to 49.97 Yuan From 55.47 Yuan, Keeps at Buy MT
Nomura Adjusts SonoScape Medical’s Price Target to 55.47 Yuan From 65.59 Yuan, Keeps at Buy MT
Nomura Adjusts SonoScape Medical's Price Target to 65.59 Yuan From 66.37 Yuan, Keeps at Buy MT
Nomura Adjusts SonoScape Medical's Price Target to 66.37 Yuan From 66.55 Yuan, Keeps at Buy MT
Nomura Adjusts Sonoscape Medical’s Price Target to 66.55 Yuan From 64.39 Yuan, Keeps at Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
41.3 CNY
Average target price
49.46 CNY
Spread / Average Target
+19.75%
High Price Target
58 CNY
Spread / Highest target
+40.44%
Low Price Target
42.57 CNY
Spread / Lowest Target
+3.08%

Consensus detail

Consensus revision (last 18 months)

Analysts covering SonoScape Medical Corp.

Nomura

Ratings for SonoScape Medical Corp.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 300633 Stock
  4. Consensus SonoScape Medical Corp.